Merck & Co. Total Assets decreased by 98.6% to $1.82B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 98.4%, from $117.11B to $1.82B. Over 5 years (FY 2020 to FY 2025), Total Assets shows a downward trend with a -54.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth indicates business expansion and capital investment, while a decline might suggest asset divestitures or significant depreciation.
The sum of all resources owned or controlled by the company, including both current items like cash and non-current item...
Used to calculate Return on Assets (ROA); tech giants typically have massive asset bases driven by cash reserves and infrastructure.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $90.69B | $93.49B | $105.69B | $106.67B | $107.10B | $107.08B | $109.16B | $107.80B | $104.47B | $106.73B | $106.68B | $105.85B | $112.63B | $117.53B | $117.11B | $115.12B | $117.52B | $129.55B | $1.82B |
| QoQ Change | — | +3.1% | +13.0% | +0.9% | +0.4% | -0.0% | +1.9% | -1.2% | -3.1% | +2.2% | -0.0% | -0.8% | +6.4% | +4.4% | -0.4% | -1.7% | +2.1% | +10.2% | -98.6% |
| YoY Change | — | — | — | — | +18.1% | +14.5% | +3.3% | +1.1% | -2.5% | -0.3% | -2.3% | -1.8% | +7.8% | +10.1% | +9.8% | +8.8% | +4.3% | +10.2% | -98.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.